CA Healthcare Acquisition Corp. (CAHC)
| Market Cap | 173.36M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 14.38M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 822,772 |
| Open | 10.00 |
| Previous Close | 10.00 |
| Day's Range | 9.67 - 10.80 |
| 52-Week Range | 9.55 - 10.80 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | 14.75 (+46.8%) |
| Est. Earnings Date | n/a |
About CAHC
CA Healthcare Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more operating businesses. CA Healthcare Acquisition Corp. was founded in 2020 and is based in Boston, Massachusetts.
News
CA Healthcare Acquisition Corp. and LumiraDx Limited Announce Effectiveness of Registration Statement and September 2...
BOSTON--(BUSINESS WIRE)--CA Healthcare and LumiraDx Announce Effectiveness of Registration Statement and September 28, 2021 Special Meeting to Approve Business Combination
LumiraDx and CA Healthcare Acquisition Corp Revise Transaction Terms, Expanded Strategic Roadmap for Next-Generation ...
BOSTON & LONDON--(BUSINESS WIRE)--LumiraDx and CA Healthcare Acquisition Corp Revise Transaction Terms, Expanded Strategic Roadmap for Next-Generation Point-of-Care Diagnostics
INVESTIGATION ALERT: Halper Sadeh LLP Investigates MCAD, CAHC, ROT, MUDS, LATN; Shareholders are Encouraged to Contac...
NEW YORK, April 29, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Mountain Crest Acquisition Corp. II (NASDAQ: MCAD) c...
Covid Testing Company LumiraDx Goes Public in SPAC
Apr.07 -- LumiraDx Ltd., a diagnostic company that produces Covid-19 tests, is going public through a reverse merger with a blank-check company.
LumiraDx, a Next-Generation Point of Care Diagnostics Testing Company to List on Nasdaq via Merger with CA Healthcare...
BOSTON & LONDON--(BUSINESS WIRE)--LumiraDx, a Next-Generation Point of Care Diagnostics Testing Company to List on Nasdaq via Merger with CA Healthcare Acquisition Corp
CA Healthcare Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing M...
BOSTON--(BUSINESS WIRE)--CA Healthcare Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing March 9, 2021
CA Healthcare Acquisition Corp. Announces Closing of $115,000,000 Initial Public Offering
BOSTON--(BUSINESS WIRE)--CA Healthcare Acquisition Corp. Announces Closing of $115,000,000 Initial Public Offering
Healthcare SPAC CA Healthcare Acquisition files for a $100 million IPO
CA Healthcare Acquisition, a blank check company targeting the healthcare industry, filed on Friday with the SEC to raise up to $100 million in an initial public offering.
CA Healthcare Acquisition IPO Registration Document (S-1)
CA Healthcare Acquisition Corp. has filed to go public with an IPO on the NASDAQ.